BJL
DERM icon

Brighton Jones LLC’s Journey Medical DERM Stock Holding History

Brighton Jones LLC’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.3K Buy
+12,436
New +$96.5K ﹤0.01% 1156
2025
Q4 		– Sell
-16,842
Closed -$120K – 260
2025
Q3 		$120K Buy
16,842
+22
+0.1% +$160 ﹤0.01% 986
2025
Q2 		$121K Sell
16,820
-6,200
-27% -$42.8K ﹤0.01% 885
2025
Q1 		$136K Hold
23,020
– – ﹤0.01% 673
2024
Q4 		$90K Hold
23,020
– – ﹤0.01% 663
2024
Q3 		$130K Hold
23,020
– – ﹤0.01% 555
2024
Q2 		$130K Hold
23,020
– – ﹤0.01% 598
2024
Q1 		$84.7K Hold
23,020
– – ﹤0.01% 613
2023
Q4 		$133K Hold
23,020
– – 0.01% 558
2023
Q3 		$63.1K Hold
23,020
– – ﹤0.01% 531
2023
Q2 		$36.6K Buy
+23,020
New +$37K ﹤0.01% 538

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brighton Jones LLC's DERM Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in Journey Medical (DERM) in Q1 2026: 12,436 shares worth $58.3K. The stake represents ﹤0.01% of the portfolio and ranks #1156 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in DERM as recently as Q3 2025.

Brighton Jones LLC first reported a position in DERM in Q2 2023 and has held it in 11 quarters since. The position peaked at $136K in Q1 2025. 72 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Brighton Jones LLC held 12,436 shares of Journey Medical worth $58.3K as of Q1 2026.
  • Journey Medical was a new Brighton Jones LLC position in Q1 2026.
  • Journey Medical made up ﹤0.01% of Brighton Jones LLC's portfolio in Q1 2026, its #1156 holding.
  • Brighton Jones LLC first reported a position in Journey Medical in Q2 2023 and has held it in 11 quarters since.
  • Brighton Jones LLC's Journey Medical position peaked at $136K in Q1 2025.
  • 72 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.